Tianjin Tianyao Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 600488.SS

Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue for the year ending December 31, 2023: USD 532.81 M

Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue is USD 532.81 M for the year ending December 31, 2023, a -0.33% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue for the year ending December 31, 2022 was USD 534.56 M, a -9.39% change year over year.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue for the year ending December 31, 2021 was USD 589.96 M, a 23.55% change year over year.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue for the year ending December 31, 2020 was USD 477.50 M, a 14.05% change year over year.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Revenue for the year ending December 31, 2019 was USD 418.69 M, a 18.61% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 600488.SS

Tianjin Tianyao Pharmaceuticals Co., Ltd.

CEO	Mr. Shuxiang Li
IPO Date	June 18, 2001
Location	China
Headquarters	No. 19, Xinye 9th Street
Employees	2,678
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Chemicals & Advanced Materials Drugstores & Retail Pharmacies Personal Care Petrochemicals Plastics

Description

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.

Key trends

Past 5 years